Urgent-use & shortage drug compounding legislation (HR 3662)
Americans needed help in the pandemic. Compounders stepped up, with FDA’s permission. Now the agency should acknowledge how much more compounders can do … and let them do it.
HR 3662 would create a narrow but permanent path for 503A compounding pharmacies to prepare urgent-use medications for hospitals and physician specialists when those medications are not available from manufacturers or 503B outsourcing facilities.